|
TV Spot on EpiPen Pulled After FDA Warning Letter
Pfizer agreed to pull a 60-second direct-to-consumer (DTC) TV ad promoting a pair of drug-device combination products to treat severe allergic reactions after the FDA flagged it for overstating the products’ efficacy.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives